C. Bonne

2.7k total citations
99 papers, 2.0k citations indexed

About

C. Bonne is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, C. Bonne has authored 99 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Physiology and 18 papers in Pharmacology. Recurrent topics in C. Bonne's work include Inflammatory mediators and NSAID effects (14 papers), Hormonal and reproductive studies (12 papers) and Nitric Oxide and Endothelin Effects (11 papers). C. Bonne is often cited by papers focused on Inflammatory mediators and NSAID effects (14 papers), Hormonal and reproductive studies (12 papers) and Nitric Oxide and Endothelin Effects (11 papers). C. Bonne collaborates with scholars based in France, Canada and Russia. C. Bonne's co-authors include Jean‐Pierre Raynaud, Agnès Müller, Max Villain, Fernand Labrie, Chantal Cazevieille, Y Gourdeau, Jacques Asselin, A. Müller, M. Moguilewsky and F Regnault and has published in prestigious journals such as Free Radical Biology and Medicine, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

C. Bonne

99 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bonne France 24 742 498 343 309 257 99 2.0k
Takanobu Taniguchi Japan 33 1.5k 2.1× 373 0.7× 473 1.4× 436 1.4× 184 0.7× 105 3.1k
Kazuhiro Oka United States 34 1.9k 2.6× 456 0.9× 391 1.1× 770 2.5× 104 0.4× 74 3.8k
Evelyn F. Grollman United States 31 1.6k 2.2× 1.1k 2.3× 479 1.4× 413 1.3× 106 0.4× 61 3.1k
Krishna G. Peri Canada 29 954 1.3× 85 0.2× 448 1.3× 343 1.1× 145 0.6× 55 2.1k
John E. Bleasdale United States 25 1.8k 2.5× 236 0.5× 641 1.9× 187 0.6× 285 1.1× 56 3.7k
Kikuko Watanabe Japan 32 1.1k 1.5× 242 0.5× 337 1.0× 600 1.9× 80 0.3× 72 3.0k
Eduardo G. Lapetina United States 38 2.4k 3.2× 294 0.6× 963 2.8× 460 1.5× 171 0.7× 87 4.4k
Joo‐Won Jeong South Korea 27 1.6k 2.2× 134 0.3× 309 0.9× 230 0.7× 221 0.9× 57 3.1k
Susan P. LeDoux United States 41 3.2k 4.3× 213 0.4× 640 1.9× 314 1.0× 222 0.9× 68 4.6k
Robert L. Sorenson United States 37 1.5k 2.0× 1.8k 3.7× 443 1.3× 1.5k 4.9× 55 0.2× 96 4.7k

Countries citing papers authored by C. Bonne

Since Specialization
Citations

This map shows the geographic impact of C. Bonne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bonne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bonne more than expected).

Fields of papers citing papers by C. Bonne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bonne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bonne. The network helps show where C. Bonne may publish in the future.

Co-authorship network of co-authors of C. Bonne

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bonne. A scholar is included among the top collaborators of C. Bonne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bonne. C. Bonne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonne, C.. (2016). Potential efficiency of antioxidants to prevent pressure ulcers. A neglected hypothesis. Medical Hypotheses. 91. 28–31. 3 indexed citations
2.
Bonne, C.. (2005). Le PPAR gamma : une nouvelle cible pharmacologique contre la néovascularisation rétinienne et choroïdienne. Journal Français d Ophtalmologie. 28(3). 326–330. 8 indexed citations
3.
Bonne, C., Agnès Müller, & Max Villain. (1998). Free Radicals in Retinal Ischemia*. General Pharmacology The Vascular System. 30(3). 275–280. 130 indexed citations
4.
Müller, Agnès, Sylvia Pietri, Max Villain, et al.. (1997). Free Radicals in Rabbit Retina Under Ocular Hyperpressure and Functional Consequences. Experimental Eye Research. 64(4). 637–643. 45 indexed citations
5.
Villain, Max, et al.. (1996). Differential Effect of Ischemia/Reperfusion on Pigmented and Albino Rabbit Retina. Journal of Ocular Pharmacology and Therapeutics. 12(3). 337–342. 5 indexed citations
6.
Culcasi, Marcel, Chantal Cazevieille, Sylvia Pietri, et al.. (1995). Calcium-dependent free radical generation in cultured retinal neurons injured by kainate. Neuroscience Letters. 198(1). 13–16. 38 indexed citations
7.
Bonne, C., et al.. (1994). Inhibition of Cell Adhesion to Lens Capsule by LCM 1910, an RGD-Derived Peptide. Journal of Ocular Pharmacology and Therapeutics. 10(4). 623–632. 8 indexed citations
8.
Cazevieille, Chantal, Agnès Müller, & C. Bonne. (1993). Prostacyclin (PGI2) protects rat cortical neurons in culture against hypoxia/reoxygenation and glutamate-induced injury. Neuroscience Letters. 160(1). 106–108. 38 indexed citations
9.
10.
Vidal, Jean‐Pierre, Roger Escale, Thierry Durand, et al.. (1992). Synthesis and contractile activity of new pseudopeptido and thioaromatic analogues of leukotriene D4. Prostaglandins. 43(1). 45–54. 5 indexed citations
11.
Bonne, C., et al.. (1992). Alterations of energetic metabolite levels by free radicals during optic nerve ischemia. Current Eye Research. 11(3). 275–278. 4 indexed citations
12.
Bonne, C., et al.. (1991). Hypoxia/reoxygenation alters endothelial prostacyclin synthesis—Protection by superoxide dismutase. Free Radical Biology and Medicine. 11(3). 269–275. 27 indexed citations
13.
Müller, Andreas, et al.. (1990). PAF-Induced Conjunctivitis in the Rabbit is Mediated by Peptido-Leukotrienes. Journal of Ocular Pharmacology and Therapeutics. 6(3). 227–232. 8 indexed citations
14.
Junquéro, Didier, et al.. (1990). Retinoids enhance the number of EGF receptors in corneal endothelial cells. Experimental Eye Research. 51(1). 49–53. 4 indexed citations
15.
Bonne, C., et al.. (1990). Free Radical Scavenging Capacity and Anti-Inflammatory Activity of CBS-113 A. Advances in experimental medicine and biology. 264. 257–259. 1 indexed citations
16.
Müller, Andreas, Jean‐Paul Lellouche, J. P. Beaucourt, et al.. (1989). Comparative biological activities of the four synthetic (5,6)-dihete isomers. Prostaglandins. 38(6). 635–644. 7 indexed citations
17.
Bonne, C., et al.. (1988). Screening tests of free radical scavengers for preventing sun‐accelerated cutaneous ageing. International Journal of Cosmetic Science. 10(5). 247–252. 2 indexed citations
18.
Bonne, C., et al.. (1988). Oxidative Stress and Lens Opacity: An Overall Approach to Screening Anticataractous Drugs. Ophthalmic Research. 20(1). 27–30. 8 indexed citations
19.
Bonne, C., et al.. (1981). A new model for the assay of comedolytic activity. International Journal of Cosmetic Science. 3(1). 23–28. 2 indexed citations
20.
Bonne, C., N. Romquin, & F Regnault. (1979). Modified sensitivity of diabetic platelets to prostacyclin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 98–103. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026